| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.4 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |